Mesothelioma Victims Center to Assess Victims for IPF


by |

Share this article:

Share article via email
asbestos and IPF

asbestos and IPFAsbestos exposure has traditionally been linked to Mesothelioma. Now, however, IPF is also being associated with exposure to asbestos in some cases as well.

Mesothelioma, a rare type of cancer that affects the protective lining of internal organs, is a common consequence of asbestos exposure. It can develop in the peritoneum, pericardium or tunica vaginalis, but the most common site is in the pleura — the outer, protective lining of the lungs. The Mesothelioma Victims Center recognizes that workers who were exposed to asbestos in the workplace back in the 60s, 70s and 80s are at risk for developing this type of cancer, and is strengthening its efforts this week to administer medical checkups, which will also screen patients for other diseases linked with asbestos exposure.

One of the other diseases linked with asbestos exposure is idiopathic pulmonary fibrosis (IPF), which causes spontaneous lung scarring and ultimately leads to lung failure. Science has yet to determine what causes IPF, but a study from the Imperial College of London suggests those who are diagnosed with IPF were probably unaware of their exposure to asbestos, as even washing items from an asbestos-saturated environment is harmful.

[adrotate group=”3″]

Now, the Mesothelioma Victims Center is encouraging those who had exposure to asbestos to be screened for IPF as another possible consequence of the exposure. Aside from providing medical checkups, the center will give those diagnosed with mesothelioma secondary to asbestos exposure access to some of the most skilled compensation lawyers in the country.

In other pulmonary fibrosis news, a specialist in Korean traditional medicine and head of the Pyunkang Korean Medicine Hospital is visiting New York for a week to promote a Korean herbal medicine composed of 10 natural ingredients for the treatment of chronic lung conditions like asthma, atopic dermatitis, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD).